ClinicalTrialsFinder

Lichen Planopilaris Clinical Trials in New York, New York

1 recruitingNew York, New York

Showing 1–1 of 1 trials

Recruiting
Phase 2

Safety and Biomarker Responses of Delgocitinib (JAK1,2,3/TYK2 Inhibitor) in Central Centrifugal Cicatricial Alopecia and Lichen Planopilaris

Central Centrifugal Cicatricial AlopeciaLichen Planopilaris
Icahn School of Medicine at Mount Sinai30 enrolled1 locationNCT07487948